375 PHEASANT RUN NEWTOWN, PA 18940 Get Directions
375 PHEASANT RUN NEWTOWN, PA 18940 Get Directions
Onconova Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development of new therapies for the treatment of cancer and radiation injury. Using a proprietary chemistry platform, Onconova develops small molecule therapeutics directed against pathways involved in signal transduction, cell-cycle, and DNA repair pathways.
Onconova has developed a pipeline of anti-cancer products to treat a wide variety of cancers while not impacting normal cells. These molecules were discovered using an extensive proprietary chemical library of selective anti-cancer agents designed to work against specific molecular and cellular targets. Many of these compounds are currently in various stages of development—from pre-clinical work to the Phase III setting.
Onconova Therapeutics, Inc. is creating novel solutions for oncology that unequivocally benefit patients, empower healthcare professionals, and provide significant value and satisfaction to our customers and shareholders. At Onconova, we seek to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.